| Mar'20 | Dec'19 | Sep'19 | Jun'19 | Mar'19 | Dec'18 | Sep'18 | Jun'18 | Mar'18 | Sep'17 | Jun'17 |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
196,043 | 166,979 | 135,574 | 94,520 | 58,360 | 43,130 | 33,005 | 27,950 | 0 | 0 | 0 |
Cost of sales | ||||||||||
- | - | 98,929 | 70,660 | - | - | 0 | 0 | 0 | 0 | 0 |
Gross profit | ||||||||||
-18,011 | -23,496 | 36,645 | 23,860 | 15,764 | 14,275 | 14,108 | 13,748 | 0 | 0 | 0 |
General and administrative expenses | ||||||||||
86,810 | 81,968 | 62,350 | 49,373 | 38,250 | 29,461 | 19,404 | 14,837 | 0 | 0 | 0 |
Sales and marketing expenses | ||||||||||
71,139 | 61,084 | 45,466 | 31,985 | 20,924 | 15,366 | 10,530 | 8,552 | 0 | 0 | 0 |
Research and development expenses | ||||||||||
6,768 | 6,558 | 6,739 | 5,226 | 4,337 | 4,264 | 3,145 | 3,383 | 0 | 0 | 0 |
Stock-based compensation expenses | ||||||||||
33,783 | 31,842 | 25,747 | 28,677 | 26,693 | 20,988 | 16,912 | 5,702 | 0 | 0 | 0 |
Depreciation and amortization expenses | ||||||||||
13,333 | 11,607 | 8,006 | 5,345 | 3,241 | 1,598 | 0 | 0 | 0 | - | - |
Impairment of assets | ||||||||||
0 | - | - | - | - | - | - | - | - | - | - |
Acquisition-related expenses, net | ||||||||||
0 | - | 0 | - | 0 | - | 0 | - | - | - | - |
Loss from equity method investments | ||||||||||
0 | - | 0 | - | - | - | - | - | - | - | - |
Acquisition and integration expenses | ||||||||||
- | - | - | 0 | - | - | - | - | - | - | - |
Operating loss | ||||||||||
-344,509 | -301,702 | -107,172 | -103,882 | -82,353 | -57,650 | -36,925 | -19,229 | 0 | 0 | 0 |
Foreign exchange loss, net | ||||||||||
-21,946 | 5,944 | -7,474 | -3,298 | -6,267 | -7,234 | -75 | -1,305 | 0 | 0 | 0 |
Change in fair value of warrant liability | ||||||||||
0 | - | - | - | - | - | - | - | - | - | - |
Interest expenses, net | ||||||||||
-35,092 | -34,690 | -33,734 | -25,527 | -17,438 | -9,110 | -1,825 | -845 | 0 | 0 | 0 |
Finance income from ABG | ||||||||||
- | - | - | - | 0 | - | - | - | - | - | - |
Other expense (income), net | ||||||||||
-5,995 | 2,501 | 8,781 | 7,693 | 5,734 | 2,010 | 431 | 186 | 0 | 0 | 0 |
Loss before income taxes | ||||||||||
-481,327 | -329,619 | -139,232 | -124,857 | -100,379 | -72,174 | -38,394 | -22,153 | 0 | 0 | 0 |
Deferred income tax recoveries | ||||||||||
-6,342 | -8,847 | 0 | 0 | 0 | - | - | - | - | - | - |
Current income tax expenses (benefit) | ||||||||||
938 | 397 | 426 | 294 | 0 | - | 0 | 0 | - | 0 | 0 |
Net loss | ||||||||||
-475,923 | -321,169 | -131,109 | -114,131 | -91,911 | -67,723 | -38,481 | -22,216 | 0 | 0 | 0 |
Net loss per share - basic and diluted | ||||||||||
-1.73 | -2.17 | -0.36 | -0.36 | -0.31 | -0.38 | -0.20 | -0.17 | -0.07 | -0.02 | -0.01 |
Weighted average shares used in computation of net loss per share - basic and diluted | ||||||||||
106,463 | 111,585 | 98,130 | 97,231 | 94,875 | 88,894 | 93,144 | 75,000 | 75,000 | 75,000 | 75,000 |
Net loss | ||||||||||
-475,923 | -321,169 | -131,109 | -114,131 | -91,911 | -67,723 | -38,481 | -22,216 | 0 | 0 | 0 |
Foreign currency translation loss, net | ||||||||||
-10,984 | 5,174 | -1,214 | 3,198 | 188 | 662 | -539 | -296 | 0 | 0 | 0 |
Unrealized (loss) gain on available-for-sale debt securities | ||||||||||
0 | - | - | - | 0 | - | - | - | - | - | - |
Unrealized loss on investments | ||||||||||
- | - | 0 | 0 | - | - | - | - | - | - | - |
Other comprehensive loss | ||||||||||
-11,098 | 5,153 | -3,023 | 1,690 | -558 | -103 | 0 | 0 | 0 | - | - |
Comprehensive loss | ||||||||||
-487,021 | -316,016 | -134,132 | -112,441 | -92,469 | -67,826 | -39,020 | -22,512 | 0 | 0 | 0 |
Product Costs [Member] | ||||||||||
Cost of sales | ||||||||||
0 | - | - | - | 0 | - | - | - | - | - | - |
Inventory Valuation Adjustments [Member] | ||||||||||
Cost of sales | ||||||||||
0 | - | - | - | 0 | - | - | - | - | - | - |
ABG Intermediate Holdings Two LLC [Member] | ||||||||||
Finance income from ABG Profit Participation Arrangement | ||||||||||
- | - | 0 | 0 | - | - | - | - | - | - | - |